|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.981
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.947
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.886
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.881
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.879
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.853
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.790
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.725
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.723
|
|
|
|
positive regulation of retinoic acid receptor signaling pathway
|
GO:0048386 |
3 |
0.631
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.629
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.507
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.481
|
Mouse |
|
|
positive regulation of chromatin modification
|
GO:1903310 |
30 |
0.466
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.452
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.432
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.424
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
3 |
0.422
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.421
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.409
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.402
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.398
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.387
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.377
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.340
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.314
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.308
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.273
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.270
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.263
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.253
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.247
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.244
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.243
|
|
|
|
response to activity
|
GO:0014823 |
0 |
0.231
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.229
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.216
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.214
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.206
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.206
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
21 |
0.203
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.197
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.197
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.188
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.180
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.176
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.175
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.173
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.168
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.165
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.157
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.156
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.150
|
Mouse |
|
|
rhythmic process
|
GO:0048511 |
31 |
0.149
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.148
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.147
|
|
|
|
growth
|
GO:0040007 |
202 |
0.143
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.140
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.140
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.138
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.138
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.131
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.131
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.128
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
29 |
0.125
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.123
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.119
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.116
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.115
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.114
|
|
|
|
regulation of cardiac muscle hypertrophy in response to stress
|
GO:1903242 |
2 |
0.113
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.110
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.106
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.104
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.103
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
1 |
0.103
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.102
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.101
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.101
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.099
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.098
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.096
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.096
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.096
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.096
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.095
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.095
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.095
|
|
|
|
histone h3 k9 modification
|
GO:0061647 |
11 |
0.095
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.095
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.094
|
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.092
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.092
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.092
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.091
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.087
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.087
|
|
|
|
positive regulation of organic acid transport
|
GO:0032892 |
3 |
0.086
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.085
|
|
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
24 |
0.085
|
|
|
|
head development
|
GO:0060322 |
108 |
0.085
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.084
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.083
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
29 |
0.081
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.080
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.080
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.076
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
2 |
0.076
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.075
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.074
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
19 |
0.073
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.071
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.070
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.070
|
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.069
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.069
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.067
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.067
|
|
|
|
response to genistein
|
GO:0033595 |
1 |
0.067
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.066
|
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
4 |
0.066
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.065
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.064
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.063
|
|
|
|
response to ketone
|
GO:1901654 |
19 |
0.063
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.063
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.062
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.062
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.061
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.060
|
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.060
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.060
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.060
|
|
|
|
response to mercury ion
|
GO:0046689 |
4 |
0.059
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.059
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.059
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.059
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.058
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.057
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.057
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
5 |
0.057
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.057
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.056
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.056
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.056
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.056
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.055
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.054
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.054
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.054
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.054
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.054
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.053
|
|
|
|
response to dexamethasone
|
GO:0071548 |
1 |
0.053
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.052
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.052
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.052
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.051
|
|
|
|
positive regulation of glucocorticoid receptor signaling pathway
|
GO:2000324 |
1 |
0.051
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.050
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.050
|
|
|
|
memory
|
GO:0007613 |
3 |
0.050
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.050
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
13 |
0.049
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.049
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.049
|
Mouse |
|
|
regulation of glucocorticoid receptor signaling pathway
|
GO:2000322 |
2 |
0.048
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.048
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.048
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.048
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.047
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.047
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.047
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.047
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.046
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.045
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.045
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.045
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.045
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.044
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.044
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.044
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.044
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.043
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.043
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.043
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.043
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.043
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.043
|
|
|
|
negative regulation of histone acetylation
|
GO:0035067 |
6 |
0.041
|
|
|
|
neuronal ion channel clustering
|
GO:0045161 |
2 |
0.041
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
1 |
0.041
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.040
|
|
|
|
muscle adaptation
|
GO:0043500 |
12 |
0.039
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.039
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.039
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.039
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.039
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.039
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.039
|
|
|
|
arginine metabolic process
|
GO:0006525 |
3 |
0.037
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.036
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.036
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.036
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.036
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.036
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.036
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.035
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.035
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.035
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.035
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.035
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.034
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.034
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.034
|
|
|
|
chromatin silencing
|
GO:0006342 |
12 |
0.033
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.033
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.033
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.033
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.033
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.033
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.033
|
|
|
|
regulation of nitric oxide mediated signal transduction
|
GO:0010749 |
2 |
0.033
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.032
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.032
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.032
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.032
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.032
|
|
|
|
regulation of retinoic acid receptor signaling pathway
|
GO:0048385 |
9 |
0.032
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.031
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.031
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.031
|
|
|
|
positive regulation of muscle hypertrophy
|
GO:0014742 |
6 |
0.031
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.031
|
|
|
|
negative regulation of calcium mediated signaling
|
GO:0050849 |
4 |
0.030
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.030
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.030
|
|
|
|
response to camp
|
GO:0051591 |
25 |
0.030
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.030
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
|
|
|
dna modification
|
GO:0006304 |
27 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.029
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.029
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.029
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.029
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.029
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.029
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.028
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.028
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.028
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.028
|
|
|
|
dna methylation or demethylation
|
GO:0044728 |
19 |
0.028
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.027
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.027
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.027
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.027
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.027
|
|
|
|
maintenance of location in cell
|
GO:0051651 |
62 |
0.027
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.027
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.027
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.027
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.026
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.026
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
1 |
0.026
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.026
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.026
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.026
|
|
|
|
positive regulation of ubiquitin protein transferase activity
|
GO:0051443 |
18 |
0.026
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.026
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.026
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.026
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.025
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.025
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.025
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.025
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.025
|
|
|
|
positive regulation of cell size
|
GO:0045793 |
3 |
0.025
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.025
|
|
|
|
positive regulation of ligase activity
|
GO:0051351 |
19 |
0.025
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.025
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
41 |
0.025
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.025
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.025
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.024
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.024
|
Mouse |
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.024
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.024
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.024
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.024
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.024
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.024
|
|
|
|
regulation of ligase activity
|
GO:0051340 |
29 |
0.024
|
|
|
|
regulation of cardiac muscle adaptation
|
GO:0010612 |
2 |
0.023
|
|
|
|
histone arginine methylation
|
GO:0034969 |
6 |
0.023
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.023
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.023
|
|
|
|
protein deacylation
|
GO:0035601 |
39 |
0.023
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.023
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.023
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.023
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.022
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.022
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.022
|
|
|
|
sensory perception of sound
|
GO:0007605 |
37 |
0.022
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
2 |
0.022
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.022
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.022
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.022
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
10 |
0.021
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
2 |
0.021
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.021
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.021
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.021
|
|
|
|
aging
|
GO:0007568 |
66 |
0.021
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.021
|
|
|
|
regulation of transcription by galactose
|
GO:0000409 |
1 |
0.021
|
|
|
|
developmental pigmentation
|
GO:0048066 |
12 |
0.021
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.021
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.021
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.021
|
|
|
|
retinoic acid receptor signaling pathway
|
GO:0048384 |
13 |
0.020
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.020
|
|
|
|
histone exchange
|
GO:0043486 |
3 |
0.020
|
|
|
|
regulation of ubiquitin protein transferase activity
|
GO:0051438 |
28 |
0.020
|
|
|
|
system process
|
GO:0003008 |
349 |
0.020
|
|
|
|
negative regulation of calcineurin nfat signaling cascade
|
GO:0070885 |
2 |
0.020
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.020
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.020
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
6 |
0.020
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.020
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.020
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.020
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.020
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
63 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.019
|
|
|
|
cognition
|
GO:0050890 |
43 |
0.019
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.019
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.019
|
|
|
|
regulation of anion transport
|
GO:0044070 |
25 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.019
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.019
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.019
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.019
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.019
|
|
|
|
cellular response to epinephrine stimulus
|
GO:0071872 |
2 |
0.019
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.019
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.019
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
25 |
0.019
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.019
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.018
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.018
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.018
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.018
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.018
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.018
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.018
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.018
|
|
|
|
regulation of cardiac muscle hypertrophy
|
GO:0010611 |
10 |
0.018
|
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
3 |
0.018
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.018
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.018
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.018
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.017
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.017
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.017
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.017
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
76 |
0.017
|
|
|
|
regulation of growth rate
|
GO:0040009 |
1 |
0.017
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
53 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.017
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.017
|
|
|
|
response to water
|
GO:0009415 |
2 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.017
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.016
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.016
|
Mouse |
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.016
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.016
|
|
|
|
positive regulation of dendritic spine development
|
GO:0060999 |
2 |
0.016
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.016
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.016
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.016
|
|
|
|
negative regulation of peptidyl lysine acetylation
|
GO:2000757 |
8 |
0.016
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.016
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.016
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.016
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.016
|
|
|
|
response to vitamin
|
GO:0033273 |
13 |
0.016
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.016
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.016
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.016
|
|
|
|
organ growth
|
GO:0035265 |
12 |
0.016
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.016
|
|
|
|
histone deacetylation
|
GO:0016575 |
32 |
0.016
|
|
|
|
regulation of dna methylation
|
GO:0044030 |
2 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.015
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.015
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
3 |
0.015
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.015
|
|
|
|
cellular response to nutrient
|
GO:0031670 |
12 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.015
|
|
|
|
male meiosis
|
GO:0007140 |
1 |
0.015
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.015
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.015
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.015
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.015
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.015
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.015
|
|
|
|
dna hypermethylation
|
GO:0044026 |
1 |
0.015
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
14 |
0.015
|
|
|
|
dna methylation on cytosine
|
GO:0032776 |
3 |
0.015
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.014
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.014
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.014
|
|
|
|
regulation of myelination
|
GO:0031641 |
1 |
0.014
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.014
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.014
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.014
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.014
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.014
|
|
|
|
positive regulation of cardiac muscle cell differentiation
|
GO:2000727 |
4 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.014
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.014
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.014
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.014
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
44 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.014
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.014
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.014
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
15 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.013
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.013
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
10 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.013
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.013
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.013
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.013
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.013
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
56 |
0.013
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.013
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.013
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.013
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.013
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.013
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.013
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
35 |
0.013
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.013
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.013
|
|
|
|
response to testosterone
|
GO:0033574 |
1 |
0.013
|
|
